Anestesia e síndrome do QT longo
Anesthesia and the long QT syndrome
Michelle Nacur Lorentz; Flávio Gouveia Camelo Ramiro
Resumo
Palavras-chave
Abstract
Keywords
References
Wisely NA, Shipton EA. Long QT syndrome and anaesthesia. Eur J Anaesthesiol. 2002;19:853-859.
Bazett HC. An analysis of the time-relations of electrocardiograms. Heart. 1920;7:353-370.
Li H, Fuentes-Garcia J, Towbin JA. Current concepts in long QT syndrome. Pediatric Cardiol. 2000;21:542-550.
Towbin JA, Wang Z, Li H. Genotype and severity of long QT syndrome. Drug Metab Dispos. 2001;29:574-579.
Munger RG, Prineas RJ, Crow RS. Prolonged QT interval and risk of sudden death in South-East Asian men. Lancet. 1991;338:280-281.
Viskin S. Long QT syndromes and torsades de pointes. Lancet. 1999;354:1625-1633.
Kies SJ, Pabelick CM, Hurley HA. Anesthesia for patients with congenital long QT syndrome. Anesthesiology. 2005;102:204-210.
Jervell A. . .
Roden DM. Taking the "idio" out of "idiosyncratic": predicting torsades de pointes. Pacing Clin Electrophysiol. 1998;21:1029-1034.
Thompson A, Balser JR. Perioperative cardiac arrhythmias. Br J Anaesth. 2004;93:86-94.
Roden DM. Drug-induced prolongation of the QT interval. N Engl J Med. 2004;350:1013-1022.
Lieberman JA, Stroup TS, McEvoy JP. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med. 2005;353:1209-1223.
Curry TB, Gaver R, White RD. Acquired long QT syndrome and elective anesthesia in children. Paediatr Anaesth. 2006;16:471-478.
Yang T, Snyders D, Roden DM. Drug block of I (Kr): model systems and relevance of arrhytmias. J Cardiovasc Pharmacol. 2001;38:737-744.
Nattel S, Quantz MA. Pharmacological response of quinidine induced early after depolarisations in canine cardiac Purkinje fibers: insights into underlying ionic mechanisms. Cardiovasc Res. 1988;22:808-817.
Lazzara R. Amiodarone and torsades de pointes. Ann Intern Med. 1989;111:549-551.
Gintant GA, Limberis JT, McDermott JS. The canine Purkinje fiber: an in vitro model system for acquired long QT syndrome and drug-induced arrhythmogenesis. J Cardiovasc Pharmacol. 2001;37:607-618.
Straus SM, Sturkenboom MC, Bleumink GS. Non-cardiac QTc-prolonging drugs and the risk of sudden cardiac death. Eur Heart J. 2005;26:2007-2012.
Mok NS, Lo YK, Tsui PT. Ketoconazole induced torsades de pointes without concomitant use of QT interval-prolonging drug. J Cardiovasc Electrophysiol. 2005;16:1375-1377.
Roden DM. Drug-induced prolongation of the QT interval. N Engl J Med. 2004;350:1013-1022.
Charbit B, Albaladejo P, Funck-Bretano C. Prolongation of the QTc interval after postoperative nausea and vomiting treatment by droperidol or ondansetron. Anesthesiology. 2005;102:1094-1100.
Kudoh A. Perioperative management for chronic schizophrenic patients. Anesth Analg. 2005;101:1867-1872.
Zareba W, Moss AJ, Daubert JP. Implantable cardioverter defibrillator in high-risk long QT syndrome patients. J Cardiovasc Electrophysiol. 2003;14:337-341.
Moss AJ, Zareba N, Hall WJ. Effectiveness and limitations of beta-blocker therapy in congenital long-QT syndrome. Circulation. 2000;101:616-623.
Schwartz PJ, Snebold NG, Brow AM. Effects on unilateral cardiac sympathetic denervation on the ventricular fibrillation threshold. Am J Cardiol. 1976;37:1034-1040.